Skip to content

Clinical trials

Phase 2 Inflammatory Bowel Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 2 Country / region: France Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20121
20131
20152
20161
20171
20181
20201
20211
20221
20244
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Recruiting3
Active, not recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Amgen2
Applied Molecular Transport2
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2
Assistance Publique - Hôpitaux de Paris1
Centre Hospitalier Universitaire de Saint Etienne1
Eli Lilly and Company1
Genentech, Inc.1
InDex Pharmaceuticals1
Palisade Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases19
Colitis, Ulcerative9
Crohn Disease6
Colitis4
Gastrointestinal Diseases3
Cholangitis, Sclerosing1
Colonic Diseases1
Digestive System Diseases1
Inflammation1
Intestinal Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.